What is the efficacy of daratumumab in treating patients with refractory T-cell acute lymphoblastic leukemia (T-ALL) post stem cell transplant?
No direct evidence for the efficacy of daratumumab in treating patients with refractory T-ALL post-stem cell transplant was identified, though some evidence from broader contexts suggests potential efficacy in related populations.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-12
- DOI
- https://doi.org/10.5281/zenodo.24172362
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00